Literature DB >> 15167163

Validation of the German version of the Chronic Liver Disease Questionnaire.

Winfried Häuser1, Martina Schnur, Ulf Steder-Neukamm, Fritz A Muthny, Daniel Grandt.   

Abstract

OBJECTIVE: The Chronic Liver Disease Questionnaire is an instrument for the assessment of health-related quality of life in patients with chronic liver diseases. So far it has not been validated for German speaking countries.
METHODS: Two hundred and three consecutive patients with chronic liver diseases (age, 52.7 +/- 13.9 years; 47% female; 45% no cirrhosis, 21% Child's class A, 15% Child's class B and 17% Child's class C cirrhosis; 52% with chronic viral hepatitis, 32% with alcoholic and 16% with other liver diseases) of a liver centre completed the German version of the Chronic Liver Disease Questionnaire (CLDQ-D), the Short Form Health Survey SF-36, the Hospital Anxiety and Depression Scale (HADS) and the Giessener Symptom List GBB-24. Fifty stable patients filled in the CLDQ-D a second time within 3 - 8 days.
RESULTS: With 97.7% completed items the acceptance by the patients was high. The internal consistency (Cronbach alpha) for the subscales ranged from 0.69 to 0.95, the test-retest reliability ranged from 0.79 to 0.88. The correlation coefficients with similar subscales of the instruments used for validation ranged between 0.5 and 0.9 (convergent validity). Patients with liver cirrhosis Child-Pugh stage C scored significantly lower in the subscales 'Abdominal Symptoms', 'Activity' and 'Worry', indicating a reduced health-related quality of life than in patients without cirrhosis (P < 0.05) (discriminant validity).
CONCLUSION: The CLDQ-D is well accepted by patients with chronic liver diseases and has good reliability and satisfactory discriminant validity.

Entities:  

Mesh:

Year:  2004        PMID: 15167163     DOI: 10.1097/00042737-200406000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  23 in total

1.  Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.

Authors:  Evangelos Kalaitzakis; Maria Benito de Valle; Monira Rahman; Björn Lindkvist; Einar Björnsson; Roger Chapman; Nick Kontodimopoulos
Journal:  Qual Life Res       Date:  2015-10-15       Impact factor: 4.147

2.  Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.

Authors:  Jolanta Sumskiene; Linas Sumskas; Dalius Petrauskas; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Psychometrics of the chronic liver disease questionnaire for Southern Chinese patients with chronic hepatitis B virus infection.

Authors:  Elegance Ting Pui Lam; Cindy Lo Kuen Lam; Ching Lung Lai; Man Fung Yuen; Daniel Yee Tak Fong
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

4.  Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients.

Authors:  Kai-Na Zhou; Min Zhang; Qian Wu; Zhen-Hao Ji; Xiao-Mei Zhang; Gui-Hua Zhuang
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

5.  Validation of the Brazilian version of Chronic Liver Disease Questionnaire.

Authors:  Samantha Mucci; Vanessa de Albuquerque Citero; Adriano Miziara Gonzalez; Luciana Geocze; Stephan Geocze; Gaspar de Jesus Lopes Filho; Mario Alfredo De Marco; Edison Roberto Parise; Luiz Antonio Nogueira Martins
Journal:  Qual Life Res       Date:  2012-03-03       Impact factor: 4.147

6.  Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.

Authors:  Janus P Ong; Gerd Oehler; Christiane Krüger-Jansen; Judith Lambert-Baumann; Zobair M Younossi
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

7.  Health-Related Quality of Life in Portuguese Patients with Chronic Hepatitis C.

Authors:  Andreia Rei; Marta Rocha; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2016-12-03

8.  Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ).

Authors:  Hilda Mahmoudi; Peyman Jafari; Mahvash Alizadeh-Naini; Siyavash Gholami; Seyed Ali Malek-Hosseini; Sina Ghaffaripour
Journal:  Qual Life Res       Date:  2011-11-13       Impact factor: 4.147

9.  The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ).

Authors:  Karl-Heinz Schulz; Sylvia Kroencke; Heike Ewers; Holger Schulz; Zobair M Younossi
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

10.  Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire.

Authors:  Irene Ray; Deep Dutta; Pallavi Basu; Binay K De
Journal:  Indian J Gastroenterol       Date:  2010-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.